Logo image of BKSY

BLACKSKY TECHNOLOGY INC (BKSY) Stock Fundamental Analysis

NYSE:BKSY - US09263B2079 - Common Stock

17.53 USD
+0.25 (+1.45%)
Last: 8/25/2025, 8:06:33 PM
17.75 USD
+0.22 (+1.25%)
After Hours: 8/25/2025, 8:06:33 PM
Fundamental Rating

3

Overall BKSY gets a fundamental rating of 3 out of 10. We evaluated BKSY against 81 industry peers in the Professional Services industry. While BKSY seems to be doing ok healthwise, there are quite some concerns on its profitability. BKSY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BKSY has reported negative net income.
BKSY had a positive operating cash flow in the past year.
BKSY had negative earnings in each of the past 5 years.
In the past 5 years BKSY always reported negative operating cash flow.
BKSY Yearly Net Income VS EBIT VS OCF VS FCFBKSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

BKSY has a worse Return On Assets (-27.69%) than 88.89% of its industry peers.
BKSY's Return On Equity of -99.43% is on the low side compared to the rest of the industry. BKSY is outperformed by 86.42% of its industry peers.
Industry RankSector Rank
ROA -27.69%
ROE -99.43%
ROIC N/A
ROA(3y)-26.08%
ROA(5y)-34.97%
ROE(3y)-59.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKSY Yearly ROA, ROE, ROICBKSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

BKSY's Gross Margin of 69.08% is amongst the best of the industry. BKSY outperforms 85.19% of its industry peers.
In the last couple of years the Gross Margin of BKSY has grown nicely.
The Profit Margin and Operating Margin are not available for BKSY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y35.19%
BKSY Yearly Profit, Operating, Gross MarginsBKSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

4

2. Health

2.1 Basic Checks

BKSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BKSY has more shares outstanding
Compared to 5 years ago, BKSY has less shares outstanding
BKSY has a worse debt/assets ratio than last year.
BKSY Yearly Shares OutstandingBKSY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BKSY Yearly Total Debt VS Total AssetsBKSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -1.29, we must say that BKSY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.29, BKSY is not doing good in the industry: 85.19% of the companies in the same industry are doing better.
The Debt to FCF ratio of BKSY is 61.70, which is on the high side as it means it would take BKSY, 61.70 years of fcf income to pay off all of its debts.
BKSY has a worse Debt to FCF ratio (61.70) than 69.14% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that BKSY has dependencies on debt financing.
BKSY's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. BKSY is outperformed by 80.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 61.7
Altman-Z -1.29
ROIC/WACCN/A
WACC7.99%
BKSY Yearly LT Debt VS Equity VS FCFBKSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.71 indicates that BKSY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.71, BKSY belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
A Quick Ratio of 3.71 indicates that BKSY has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.71, BKSY belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.71
BKSY Yearly Current Assets VS Current LiabilitesBKSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for BKSY have decreased strongly by -121.05% in the last year.
The Revenue has decreased by -1.21% in the past year.
The Revenue has been growing by 49.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-121.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y44.14%
Revenue growth 5Y49.41%
Sales Q2Q%-10.98%

3.2 Future

BKSY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.77% yearly.
Based on estimates for the next years, BKSY will show a very strong growth in Revenue. The Revenue will grow by 24.82% on average per year.
EPS Next Y26.75%
EPS Next 2Y30.54%
EPS Next 3Y25.42%
EPS Next 5Y19.77%
Revenue Next Year8.96%
Revenue Next 2Y20.86%
Revenue Next 3Y23.43%
Revenue Next 5Y24.82%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BKSY Yearly Revenue VS EstimatesBKSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
BKSY Yearly EPS VS EstimatesBKSY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15

1

4. Valuation

4.1 Price/Earnings Ratio

BKSY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKSY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKSY Price Earnings VS Forward Price EarningsBKSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

BKSY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. BKSY is more expensive than 69.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 313.16
EV/EBITDA N/A
BKSY Per share dataBKSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as BKSY's earnings are expected to grow with 25.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.54%
EPS Next 3Y25.42%

0

5. Dividend

5.1 Amount

BKSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLACKSKY TECHNOLOGY INC

NYSE:BKSY (8/25/2025, 8:06:33 PM)

After market: 17.75 +0.22 (+1.25%)

17.53

+0.25 (+1.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners45.78%
Inst Owner Change3.74%
Ins Owners2.8%
Ins Owner Change6.23%
Market Cap621.61M
Analysts83.08
Price Target24.82 (41.59%)
Short Float %15.63%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-92.64%
Min EPS beat(2)-191.5%
Max EPS beat(2)6.22%
EPS beat(4)2
Avg EPS beat(4)-100.16%
Min EPS beat(4)-215.64%
Max EPS beat(4)6.22%
EPS beat(8)5
Avg EPS beat(8)-27.23%
EPS beat(12)8
Avg EPS beat(12)-20.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-5.82%
Max Revenue beat(2)6.5%
Revenue beat(4)1
Avg Revenue beat(4)-7.97%
Min Revenue beat(4)-19.54%
Max Revenue beat(4)6.5%
Revenue beat(8)2
Avg Revenue beat(8)-2.02%
Revenue beat(12)2
Avg Revenue beat(12)-3.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)26.41%
PT rev (3m)42.09%
EPS NQ rev (1m)-52.22%
EPS NQ rev (3m)-40.51%
EPS NY rev (1m)-71.56%
EPS NY rev (3m)-67.05%
Revenue NQ rev (1m)-6.96%
Revenue NQ rev (3m)-12.87%
Revenue NY rev (1m)-12.5%
Revenue NY rev (3m)-12.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.94
P/FCF 313.16
P/OCF 32.4
P/B 7.18
P/tB 8.73
EV/EBITDA N/A
EPS(TTM)-3.36
EYN/A
EPS(NY)-0.89
Fwd EYN/A
FCF(TTM)0.06
FCFY0.32%
OCF(TTM)0.54
OCFY3.09%
SpS2.95
BVpS2.44
TBVpS2.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.69%
ROE -99.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.08%
FCFM 1.9%
ROA(3y)-26.08%
ROA(5y)-34.97%
ROE(3y)-59.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y35.19%
F-Score3
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 61.7
Debt/EBITDA N/A
Cap/Depr 47.73%
Cap/Sales 16.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.71
Quick Ratio 3.71
Altman-Z -1.29
F-Score3
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)34.25%
Cap/Depr(5y)22.9%
Cap/Sales(3y)16.46%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-121.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
EPS Next Y26.75%
EPS Next 2Y30.54%
EPS Next 3Y25.42%
EPS Next 5Y19.77%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y44.14%
Revenue growth 5Y49.41%
Sales Q2Q%-10.98%
Revenue Next Year8.96%
Revenue Next 2Y20.86%
Revenue Next 3Y23.43%
Revenue Next 5Y24.82%
EBIT growth 1Y-2.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.51%
EBIT Next 3Y53.62%
EBIT Next 5Y38.8%
FCF growth 1Y104.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.39%
OCF growth 3YN/A
OCF growth 5YN/A